These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29680823)

  • 1. Prodomain of Furin Promotes Phospholipid Transfer Protein Proteasomal Degradation in Hepatocytes.
    Yu Y; Lei X; Jiang H; Li Z; Creemers JWM; Zhang M; Qin S; Jin W; Jiang XC
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury.
    Lei X; Basu D; Li Z; Zhang M; Rudic RD; Jiang XC; Jin W
    Atherosclerosis; 2014 Sep; 236(1):121-30. PubMed ID: 25026302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.
    Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A
    Biochim Biophys Acta; 2006 Sep; 1761(9):1070-7. PubMed ID: 16935026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.
    Yazdanyar A; Quan W; Jin W; Jiang XC
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2058-64. PubMed ID: 23846500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice.
    Yazdanyar A; Jiang XC
    Hepatology; 2012 Aug; 56(2):576-84. PubMed ID: 22367708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.
    Samyn H; Moerland M; van Gent T; van Haperen R; Metso J; Grosveld F; Jauhiainen M; van Tol A; de Crom R
    J Lipid Res; 2008 Dec; 49(12):2504-12. PubMed ID: 18711210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid transfer protein plays a major role in the initiation of apolipoprotein B-containing lipoprotein assembly in mouse primary hepatocytes.
    Manchekar M; Liu Y; Sun Z; Richardson PE; Dashti N
    J Biol Chem; 2015 Mar; 290(13):8196-205. PubMed ID: 25638820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism.
    Moerland M; Anghelescu N; Samyn H; van Haperen R; van Gent T; Strouboulis J; van Tol A; Grosveld F; de Crom R
    Transgenic Res; 2007 Aug; 16(4):503-13. PubMed ID: 17437182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
    Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis.
    Jiang XC; Yu Y
    Curr Atheroscler Rep; 2021 Jan; 23(3):9. PubMed ID: 33496859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants.
    Jiang XC; Li Z; Liu R; Yang XP; Pan M; Lagrost L; Fisher EA; Williams KJ
    J Biol Chem; 2005 May; 280(18):18336-40. PubMed ID: 15734742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.
    van Haperen R; Samyn H; Moerland M; van Gent T; Peeters M; Grosveld F; van Tol A; de Crom R
    PLoS One; 2008 May; 3(5):e2255. PubMed ID: 18509527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No renal phenotype in human phospholipid transfer protein transgenic apolipoprotein E deficient mice despite severe aortic atherosclerosis.
    Dullaart RP; Van Haperen R; Van Den Born J; Van Goor H; De Crom R; Van Tol A
    Clin Lab; 2014; 60(10):1659-62. PubMed ID: 25651711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.
    Yeang C; Qin S; Chen K; Wang DQ; Jiang XC
    J Lipid Res; 2010 Oct; 51(10):2993-3002. PubMed ID: 20543142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid transfer protein destabilizes mouse atherosclerotic plaque.
    Zhang K; Liu X; Yu Y; Luo T; Wang L; Ge C; Liu X; Song J; Jiang X; Zhang Y; Qin S; Zhang M
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2537-44. PubMed ID: 25324570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein.
    Luo Y; Shelly L; Sand T; Chang G; Jiang XC
    J Pharmacol Exp Ther; 2010 Dec; 335(3):653-8. PubMed ID: 20805304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes.
    Luo Y; Shelly L; Sand T; Reidich B; Chang G; Macdougall M; Peakman MC; Jiang XC
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1100-6. PubMed ID: 19933370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.